Disinfectants are the antimicrobial agents that are applied to the various surfaces objects in order to destroy microorganisms, stagnant on them in order to prevent the spread of diseases and infections. Frequently application of surface disinfectants helps in prevention and minimizing of infections and their various adverse effects that are widespread in the hospital system.
The global disinfectants market was estimated to be valued more than US$ 30 billion in terms of revenue in 2019 and is predicted to grow at a CAGR of 6.0% during the forecast period (2020 to 2027).
Rising growth of pharmaceutical and healthcare industry across the globe. In addition to this, Hospital-acquired infections (HAIs) are the infections which occur during a patient’s stay at hospitals and related facilities but are not observed at the time of admission. These infections include hospital-acquired pneumonia, central line-associated bloodstream infections, surgical related infections, catheter-associated urinary tract infections, ventilator-associated pneumonia, and others. Owing to this, hospitals use of different types of disinfectants for cleaning of surface and disinfecting medical devices in order to reduce the incidence rates of contagious diseases further.
Companies engaged in manufacturing of disinfectants are adopting different strategies such as mergers and acquisitions, in order to expand their product portfolio and their market presence globally. For instance, in May 2020, Sonoma Pharmaceuticals, a specialty pharmaceutical company which develops healthcare solutions, partnered with MicroSafe Group, a Dubai based company involved in developing bio-technological products, for developing a new disinfectant & sanitizer named Nanocyn, The product has received approval for Australian Register of Therapeutic Goods (ARTG).
Improper usage of disinfectants can cause harmful environmental hazards and they can be exposed to patients. Implementation of stringent regulations by governments across the globe regarding approval for usage of disinfectants in pharmaceutical industry is expected to hamper the growth of the market during the forecast period.
On the basis of product type, oxidizing agents dominated the global disinfectants market in 2019 with around 51% of market share in terms of revenue, followed by phenolic and quaternary ammonium compounds, respectively.
The global disinfectants market has observed rapid growth in terms of revenue in the past few years owing to the rising demand for hypochlorites in healthcare industry. Hypochlorites are predominantly used among the chlorine disinfectants are available in both solid and liquid forms.
These disinfectants have a wide spectrum of pharmaceutical application such as fungicidal, antimicrobial, sporicidal, virucidal, bactericidal and mycobactericidal actitivties. Hypochlorites provide various advantages such as they are cost-effective, fast reacting, do not produce toxic residues resistance to hard water, and have a significantly low incidence of serious toxicity.
Global Disinfectants Market - Impact of Coronavirus (Covid-19) Pandemic
The increasing demand for disinfectants in healthcare industry owing to the spread of Covid-19 in various countries across the globe has provided lucrative growth to the global disinfectants market during second quarter of 2020. This scenario is expected to foster the growth of the market till 2021-2022.
Key players are operating in the global disinfectants market are Solvay S.A., Unilever Group, Evonik Industries AG, 3M Company, Procter & Gamble Corporation, DowDuPont Inc., Lanxess AG, BASF S.E., The Clorox Company, and Reckitt Benckiser Plc.
By Product Type
By End-User Industry